Medicure Inc. (CVE:MPH – Get Free Report) shares passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$0.88 and traded as high as C$1.17. Medicure shares last traded at C$1.17, with a volume of 800 shares trading hands.
Medicure Trading Up 17.0%
The company has a current ratio of 2.03, a quick ratio of 1.29 and a debt-to-equity ratio of 4.65. The company has a market cap of C$12.21 million, a PE ratio of -6.00 and a beta of 0.90. The stock has a 50 day moving average price of C$0.88 and a 200 day moving average price of C$0.86.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
See Also
- Five stocks we like better than Medicure
- 3 Warren Buffett Stocks to Buy Now
- Five Below Pops on Strong Earnings, But Rally May Stall
- Following Congress Stock Trades
- Intel’s Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
- What is MarketRank™? How to Use it
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
